Aurora Cannabis Receives Plant Breeders' Rights In Canada For Two Proprietary Cannabis Cultivars
Aurora Cannabis Acquires Safari Flower Company For $26.5M To Expand EU GMP Capacity And Strengthen Global Medical Cannabis Market Leadership
Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year
"The Cannabis Industry's Medical Pivot: Why Most Companies Are Already Ten Years Behind."
Implied Volatility Surging for Aurora Cannabis Stock Options
Canaccord Initiates Aurora Cannabis Inc. (ACB) With C$10 Price Target
Aurora Cannabis Pivots to Medical-Only, Eyes Germany & Australia Growth at TD Cowen Conference
Is Aurora Cannabis Stock Ready to 10X in the Next Pot Boom?
Aurora to Participate in the TD Cowen 46th Annual Health Care Conference
Canaccord is Bullish on Aurora Cannabis Inc. (ACB)
Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis
Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand
Aurora Cannabis Is Expanding Its Aurora Medical Portfolio In Australia And New Zealand
Aurora Cannabis Inc. 2026 Q3 - Results - Earnings Call Presentation
Aurora Cannabis: 3Q Revenue Jumps on Strong Medical Sales – Quarterly Update Report
Aurora Cannabis Inc. Q3 2026 Earnings Call Summary
Aurora Cannabis Reports Increased Revenue And Free Cash Flow For Q3-2026
Aurora Cannabis Inc (ACB) (Q3 2026) Earnings Call Highlights: Strategic Shifts and Global ...
Aurora Cannabis Q3 Earnings Call Highlights
Aurora Cannabis (ACB) Q3 2026 Earnings Transcript
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.